本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Propanc Biopharma, Inc.

1.78
+0.05503.19%
盤後:1.73-0.0500-2.81%19:30 EST
成交量:2.79萬
成交額:5.26萬
市值:186.59萬
市盈率:-0.02
高:2.00
開:1.79
低:1.74
收:1.73
52周最高:315.00
52周最低:1.61
股本:104.82萬
流通股本:70.66萬
量比:2.84
換手率:3.94%
股息:- -
股息率:- -
每股收益(TTM):-85.3841
每股收益(LYR):-3,712.2407
淨資產收益率:-211.03%
總資產收益率:-97.54%
市淨率:0.26
市盈率(LYR):0.00

資料載入中...

2026/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/10/29

重要事件披露

Form 8-K - Current report
2026/10/05

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/09/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/07/17

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/07/14

重要事件披露

Form 8-K - Current report
2026/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/16

SEC問詢函

Form CORRESP - Correspondence
2026/04/10

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/20

SEC問詢函

Form CORRESP - Correspondence
2026/02/19

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/02/17

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/02/13

SEC問詢函

Form CORRESP - Correspondence
2026/02/11

SEC問詢函

Form CORRESP - Correspondence
2026/02/02

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/01/07

重要事件披露

Form 8-K - Current report
2026/01/07

SEC問詢函

Form CORRESP - Correspondence
2025/12/30

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]